Incidence trends in upper GI cancer in young adults: a nationwide time-trend analysis using 2001-2019 United States Cancer Statistics databases.


Journal

The American journal of gastroenterology
ISSN: 1572-0241
Titre abrégé: Am J Gastroenterol
Pays: United States
ID NLM: 0421030

Informations de publication

Date de publication:
03 Sep 2024
Historique:
received: 24 12 2023
accepted: 27 06 2024
medline: 3 9 2024
pubmed: 3 9 2024
entrez: 3 9 2024
Statut: aheadofprint

Résumé

Upper gastrointestinal (UGI) cancers, comprised of malignancies of the esophagus, stomach, duodenum, pancreas, liver, biliary tract, and gallbladder, are the second leading cause of cancer-related mortality in the US and is associated with significant comorbidities. Recent studies show a disproportionate rise in pancreatic and stomach cancer among young adults. This study aims to use a nationwide, population-based cohort to (1) evaluate the trend of al UGI cancer as an aggregate and (2) examine the role of demographics, histology, and tumor stage in UGI cancer incidence among young adults. Individuals diagnosed with UGI cancer in the US from 2001-2019 were identified and obtained from the SEER-NPCR database. The primary outcomes were incidence rates of UGI cancer (calculated per 100,000, age-adjusted to the year 2000 US population), stratified by sex and age (< 55 years for young adults, and ≥55 years for older adults). Trends, annual percentage change (APC) and average APC (AAPC) were calculated using the parametric method. Sensitivity analysis was performed according to primary site and histology; further analysis examining race and cancer stage was performed in the young adult subgroup. A total of 2,333,161 patients with UGI cancer were identified. The majority of cases were male and 14.3% were <55 years of age. Incidence of UGI cancer increased most in women < 55 years of age, driven primarily by pancreatic and stomach cancers, as well as neuroendocrine tumor and gastrointestinal stromal tumor histology. African American race and localized tumors, and malignancy with distant spread are also contributing to the disparate increase among young women. UGI mortality rates have not changed significantly in young adults. The overall incidence rate of upper GI cancer is increasing significantly in young women compared to men. Increased endoscopic procedures and disparate exposure to risk factors are likely contributing to these trends.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Upper gastrointestinal (UGI) cancers, comprised of malignancies of the esophagus, stomach, duodenum, pancreas, liver, biliary tract, and gallbladder, are the second leading cause of cancer-related mortality in the US and is associated with significant comorbidities. Recent studies show a disproportionate rise in pancreatic and stomach cancer among young adults. This study aims to use a nationwide, population-based cohort to (1) evaluate the trend of al UGI cancer as an aggregate and (2) examine the role of demographics, histology, and tumor stage in UGI cancer incidence among young adults.
METHODS METHODS
Individuals diagnosed with UGI cancer in the US from 2001-2019 were identified and obtained from the SEER-NPCR database. The primary outcomes were incidence rates of UGI cancer (calculated per 100,000, age-adjusted to the year 2000 US population), stratified by sex and age (< 55 years for young adults, and ≥55 years for older adults). Trends, annual percentage change (APC) and average APC (AAPC) were calculated using the parametric method. Sensitivity analysis was performed according to primary site and histology; further analysis examining race and cancer stage was performed in the young adult subgroup.
RESULTS RESULTS
A total of 2,333,161 patients with UGI cancer were identified. The majority of cases were male and 14.3% were <55 years of age. Incidence of UGI cancer increased most in women < 55 years of age, driven primarily by pancreatic and stomach cancers, as well as neuroendocrine tumor and gastrointestinal stromal tumor histology. African American race and localized tumors, and malignancy with distant spread are also contributing to the disparate increase among young women. UGI mortality rates have not changed significantly in young adults.
CONCLUSION CONCLUSIONS
The overall incidence rate of upper GI cancer is increasing significantly in young women compared to men. Increased endoscopic procedures and disparate exposure to risk factors are likely contributing to these trends.

Identifiants

pubmed: 39225338
doi: 10.14309/ajg.0000000000003068
pii: 00000434-990000000-01320
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by The American College of Gastroenterology.

Auteurs

Jeff Liang (J)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Ryan Rastegar (R)

University of California Los Angeles, Los Angeles, CA, USA.

Mohamad El Helou (M)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Kushagra Mathur (K)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Brent K Larson (BK)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Kevin Waters (K)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Anila Vasireddy (A)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Navikran Randhawa (N)

Franciscan Health, Olympia Fields, IL, USA.

Muhammad Mubarak (M)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Rashmi Advani (R)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Arsen Osipov (A)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Jun Gong (J)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Andrew Hendifar (A)

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Quin Liu (Q)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Kenneth H Park (KH)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Rabindra Watson (R)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Stephen J Pandol (SJ)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Simon Lo (S)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Srinivas Gaddam (S)

Cedars-Sinai Health Systems, Los Angeles, CA, USA.

Classifications MeSH